UK Companies House feature
X-PHARM LIMITED
Profile
- Company number
- 04664432
- Status
- Active
- Incorporation
- 2003-02-12
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 47730
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Xeinadin Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Subsidiaries
- Wallgreen Limited · 100% held · England and Wales
- Ramdev Limited · 100% held · England and Wales
- Dawnchange Limited · 100% held · England and Wales
Significant events
- “The current financial year has seen a significant increase in profitability, due to the disposal of goodwill.”
- “On 26 March 2025, Pharmacy Planet Limited was de-merged from the group.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| AHMED, Farook Omar | Director | 2021-03-01 | Mar 1978 | British |
| DHALIWAL, Bhupinder Singh | Director | 2023-11-01 | Aug 1977 | British |
| SEHMI, Gurdev Singh | Director | 2015-03-01 | Oct 1976 | British |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DHALIWAL, Bhupinder Singh | Secretary | 2003-04-14 | 2010-02-05 |
| APEX COMPANY SERVICES LIMITED | Corporate Nominee Secretary | 2003-02-12 | 2003-02-14 |
| AHMED, Farook Omar | Director | 2003-04-14 | 2020-04-01 |
| DHALIWAL, Bhupinder Singh | Director | 2014-01-01 | 2022-12-24 |
| DHALIWAL, Bhupinder Singh | Director | 2011-01-19 | 2013-06-01 |
| DHALIWAL, Bhupinder Singh | Director | 2003-04-14 | 2010-02-05 |
| SEHMI, Gurdev Singh | Director | 2003-04-14 | 2014-09-01 |
| APEX NOMINEES LIMITED | Corporate Nominee Director | 2003-02-12 | 2003-02-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| X-Pharm Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-03-28 | Active |
| Pharm Planet Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-12-17 | Ceased 2025-03-28 |
| Mr Farook Omar Ahmed | Individual | Voting 25–50% | 2021-11-02 | Ceased 2024-12-17 |
| X-Pharm Investments Limited | Corporate entity | Shares 25–50% | 2021-11-02 | Ceased 2024-11-29 |
| Mr Gurdev Singh Sehmi | Individual | Voting 25–50% | 2016-04-06 | Ceased 2024-12-17 |
| Mr Bhupinder Singh Dhaliwal | Individual | Voting 25–50% | 2016-04-06 | Ceased 2024-12-17 |
| Mr Farook Omar Ahmed | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2020-04-01 |
Filing timeline
Last 20 of 148 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-11 | MR01 | mortgage | mortgage create with deed with charles court order extend with charge number charge creation date |
| 2026-03-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-03-17 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-12-31 | AA | accounts | accounts with accounts type full |
| 2025-03-28 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-03-28 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-02-24 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-02-24 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-02-21 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-02-13 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-01-05 | AA | accounts | accounts with accounts type full |
| 2024-12-17 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-12-17 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-12-17 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-12-17 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-12-05 | SH02 | capital | capital alter shares subdivision |
| 2024-11-29 | SH19 | capital | capital statement capital company with date currency figure |
| 2024-11-29 | SH20 | capital | legacy |
| 2024-11-29 | CAP-SS | insolvency | legacy |
| 2024-11-29 | RESOLUTIONS | resolution | resolution |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.